LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Verve Therapeutics (NASDAQ: VERV)

Follow NASDAQ:VERV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VERV Verve Therapeutics
Dorval Allison / officer: Chief Financial Officer
01/08/2025
Buy
$6.01
258,000
$1.551M
258,000
NASDAQ VERV Verve Therapeutics
Dorval Allison / officer: Chief Financial Officer
01/08/2025
Buy
$6.01
75,000
$451K
75,000
NASDAQ VERV Verve Therapeutics
Politi Jason / officer: Chief Technical Ops. Off.
01/08/2025
Buy
$6.01
225,000
$1.352M
225,000
NASDAQ VERV Verve Therapeutics
Kathiresan Sekar / director, officer: Chief Executive Officer
01/08/2025
Buy
$6.01
488,000
$2.933M
488,000
NASDAQ VERV Verve Therapeutics
Lister Troy / officer: Chief Scientific Officer
01/08/2025
Buy
$6.01
225,000
$1.352M
225,000
NASDAQ VERV Verve Therapeutics
Kathiresan Sekar / director, officer: Chief Executive Officer
01/08/2025
Buy
$6.01
150,000
$902K
150,000
NASDAQ VERV Verve Therapeutics
Nickerson Joan / officer: Chief Administrative Officer
01/08/2025
Buy
$6.01
225,000
$1.352M
225,000
NASDAQ VERV Verve Therapeutics
Ashe Andrew D. / officer: See Remarks
01/08/2025
Buy
$6.01
225,000
$1.352M
225,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous